公开(公告)号：US20230270692A1

公开(公告)日：2023-08-31

申请号：US17792020

申请日：2021-01-11

申请人： Pillai Universal LLC

发明人： Baskaran PILLAI ,  Murugan Girija DINESH

IPC分类号： A61K31/12 ,  A61K31/4706 ,  A61P31/14 ,  A61P35/00 ,  A61K31/704 ,  A61K31/7068 ,  A61K31/513 ,  A61K33/243 ,  A61K31/454 ,  A61K31/4745 ,  A61K31/475 ,  A61K31/05 ,  A61K31/15 ,  C07C49/255 ,  C07C49/258 ,  C07C43/253 ,  C07C251/16

CPC分类号： A61K31/12 ,  A61K31/4706 ,  A61P31/14 ,  A61P35/00 ,  A61K31/704 ,  A61K31/7068 ,  A61K31/513 ,  A61K33/243 ,  A61K31/454 ,  A61K31/4745 ,  A61K31/475 ,  A61K31/05 ,  A61K31/15 ,  C07C49/255 ,  C07C49/258 ,  C07C43/253 ,  C07C251/16

摘要： The present disclosure provides compounds and compositions that are useful in treating chronic disorders, including cancer and viral diseases.

公开(公告)号：US20230202981A1

公开(公告)日：2023-06-29

申请号：US18008332

申请日：2021-05-26

申请人： Baskaran PILLAI ,  Dinesh M.G., ,  Pillai Universal LLC

发明人： Baskaran PILLAI ,  Murugan Girija DINESH

IPC分类号： C07D213/81 ,  C07D401/06 ,  A61P35/00

CPC分类号： C07D213/81 ,  C07D401/06 ,  A61P35/00

摘要： The present invention discloses novel anti-cancer activity exhibiting compounds for treating subjects with chronic disorder, comprising of structure in accordance with Formula 1 or any derivative thereof, or a stereoisomer or tautomer thereof, pharmaceutically acceptable salt thereof, or combination thereof, in which X is H or alkyl group; Y is carbonyl group bonded to substituted/unsubstituted homo/hetero cyclic ring with at least one double bond or carboxyl group bonded to alkyl group; Z is carbonyl/carboxyl group bonded to substituted/unsubstituted homo/hetero cyclic ring with at least one double bond or alkene or o-alkyl substituted carbamate or carbonyl group bonded to branched alkyl group and W is H or amide group or carbonyl group bonded to branched alkyl group.